274 research outputs found
çç掻æ§ç©è³ªå®éåã®ããã®è€ååå€æ©èœãã€ãªã»ã³ãµãŒã®éçºãšãã®çäœèšæž¬ãžã®å¿çš
æ¬ç 究ã¯è€æ°ã®è¶
埮å°æ¶²æ§æ
å ±å€åãåæã«è§£æã§ããå€æ©èœãã€ãªã»ã³ãµãéçºããããããã®åºç€ç 究ãšããŠã(1)埮å°éæãããŒãã«ããçç掻æ§ç©è³ªã®åé¢ãšé«æ床枬å®æ³ã®ç¢ºç«ã(2)åºè³ªéžææ§é
µçŽ ã»ã³ãµã®éçºã(3)æ°Žæ¶æ¯ååãã€ã¯ããã©ã³ã¹ãå©çšããå
ç«ã»ã³ãµã®éçºã®åç 究ããŒãã«ã€ããŠæ€èšãã以äžã®çµæãåŸãã I.埮å°éæãããŒã (1)In vitroã§ã®ããªã¢ãã¬ããªã³çžå¯Ÿååçã¯çŽ20%ã§ããããã®æ€åºéçã¯500fg/40ÎŒlã§ãã£ãã (2)ããªã¢ãã¬ããªã³ã®ååã«é¢ããåºç€å®éšãã©ããå
åŽåé åéããã³èŸèã§è¡ããååæºè¶³ã®ããçµæãåŸãããã II.é
µçŽ ã»ã³ãµ (1)æ¬ç 究ã§äœè£œããã°ã«ã³ãŒã¹ãªãã·ããŒãŒåºå®åã»ã³ãµã¯ãåºè³ªéžææ§ãæ床åã³æ¿åºŠäŸåæ§ã«é¢ããŠååæºè¶³ã®ãããã®ã§ãã£ãã (2)äœæº¶åé
žçŽ 溶液äžã§ã¯ãã°ã«ã³ãŒã¹ã»ã³ãµã®æ床ã®äœäžãèªãããããããã§ãã»ã³ãé»åã¡ãã£ãšãŒã¿ãšããŠä»åšãããããšã«ããã»ã³ãµã®æ床ãç¶æã§ããã III.å
ç«ã»ã³ãµ (1)æ°Žæ¶æ¯ååããã€ã¯ããã©ã³ã¹ãšããŠçšããããšãã§ããããŸããã®æ床ã¯1Hz/ngãšããããŠé«ãã (2)æ°Žæ¶æ¯ååé»æ¥µè¡šé¢ã«ãã©ãã³ãé»è§£éåããã¢ããåºãå°å
¥åŸãã°ã«ã¿ã«ã¢ã«ããããçšãæäœ(æããIgG)ã®ã¢ããåºãšã®éã«ã·ããå¡©åºåœ¢æåå¿ãè¡ããããããã«ããæäœãé»æ¥µè¡šé¢ã«å¹çããåºå®åã§ããã (3)åçš®æ¿åºŠã®ããIgG溶液(10,30,50ÎŒg/ml)æäžã«ãã£ãŠããããŠãã£ãããšããæéå€åã§æ¯åæ°ãå€åããIgG50ÎŒg/mlæäžã®å ŽåãçŽ20ååŸã«æ倧æ¯åæ°å€å200Hzã«éãããäžæ¹ããŠã·è¡æž
ã¢ã«ããã³(10ÎŒg/ml)ãæäžããŠããIgGæäžæã«èŠ³å¯ããããããªé¡èãªæ¯åæ°å€åãèªããããªãããšããããã®åå¿ã¯éç¹ç°çã¿ã³ãã¯çµåãªã©ã«ãããã®ã§ã¯ãªããThe purpose of this research project was to accomplish the biosensors which can detect the endogenous substances influencing neuronal activity in the brain. For this purpose, the characteristics of the following sensors were studied ; (1) microdialysis sensor for separation and analysis of bioactive substances, (2) enzyme biosensor for detection of glucose immobilized with glucose oxidase and (3) a quartz crystal microbalance sensor for immunosorbent assay.1. Microdialysis biosensorNoradrenaline release in the medial prefrontal cortex and spleen of rats was studied. The detection limit of the microdialysis sensor system for noradrenaline was 500 fg/40 mul at a 3 : 1 signal to noise ratio. A series of experiments using pharmacological and physiological manipulations indicated that the noradrenaline recovered in the dialysate was mainly derived from nerve terminals.2. Enzyme biosensorGlucose oxidase was immobilized onto platinum electrode to attain stabilized activity. The concentration response characteristics and the stability of the sensor were studied for glucose concentrations of 0.1-10.0mM.Steady state response of the sensor was proportional to the glucose concentration up to 5 mM.The slope of the linear correlation of sensor response was inversely proportional to the dissolved oxygen concentration. The decrease in sensor response caused by the reduction of dissolved oxygen concentration was overcome by using ferrocene carboxialdehyde as an electron mediator.3. Quartz crystal microbalance sensorDetermination of human immunoglobulin G (IgG) was performed by using a piezoelectric crystal biosensor system, which was consist of an AT-cut quarts piezoelectriccrystal, oscillator and frequency counter. Anti-human IgG was immobilized onto the surface of the gold electrode with tyramine and glutaraldehyde. The resonant frequency shift resulting from the affinity reaction of anti-IgG and IgG correlated with a concentration of IgG in the range of 10mug/ml-50mug/ml. The crystal sensor showed no response to bovine serum albumin.ç 究課é¡/é åçªå·:05558115, ç 究æé(幎床):1993â1995åºå
žïŒãçç掻æ§ç©è³ªå®éåã®ããã®è€ååå€æ©èœãã€ãªã»ã³ãµãŒã®éçºãšãã®çäœèšæž¬ãžã®å¿çšãç 究ææå ±åæžã課é¡çªå·05558115(KAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒ)ãããæ¬æããŒã¿ã¯èè
çå ±åæžããäœ
çµç¹èªèèœãæããäºé žåãã¿ã³ã»ããç²åã®æ°èŠããæ²»çãžã®å¿çš
é沢倧åŠç°æ¥æ¬æµ·åç°å¢ç 究ã»ã³ã¿ãŒããããã¯äºé
žåãã¿ã³ã«è¶
é³æ³¢ãç
§å°ããããšã«ãã掻æ§é
žçŽ çš®(ã©ãžã«ã«åå)ãçºçããçŸè±¡ãèŠåºããããã®çŸè±¡ãããæ²»çãžã®æ°ããªææ³ãšããŠå¿çšããããšãæ¬ç 究ã®ç®çã§ãããæ¬ç³è«ç 究ã§ã¯(1)ããäºé
žåãã¿ã³å
æ¬ã¿ãŒã²ãã£ã³ã°ãªããœãŒã ã®éçºã(2)åµè£œããäºé
žåãã¿ã³ãšè¶
é³æ³¢ç
§å°æ³ãå¹é€çŽ°èã«é©çšããããšã§ãã©ã®ãããªããæ²»çã®å¹æãåŸãããã®ãæ€èšããããŠ(3)ããçµç¹(ãã现è)ã«ãããã©ãžã«ã«æ»æã®ååã¬ãã«ã®æå解æã®3ç¹ã«ã€ããŠæ€èšãè¡ã£ãã(1)é
ã«ãããŠã¯ãã»ã³ãã€ãŠã£ã«ã¹ãç¹å®ã®ã¿ã³ãã¯è³ªããªããœãŒã è¡šé¢ã«åºå®åããäºé
žåãã¿ã³å
æ¬ãªããœãŒã ã®æ§ç¯ãå®äºãããæŽã«ããã®ãªããœãŒã ãçšããŠã(2)é
ã«ãŠå¹é€çŽ°èãšã®èåå®éšããã³ãè¶
é³æ³¢ç
§å°ã«ãã现èæ»æ»
å¹æã«ã€ããŠæ€èšãè¡ããäºé
žåãã¿ã³ã®å¹ççåã蟌ã¿ãšãåã蟌ãã 现èã«ãããè¶
é³æ³¢ç
§å°ã«ããå¹æçãªçŽ°èæ»æ»
çŸè±¡ã確èªã§ããããããŠ(3)é
ã§ã¯ã现èã®æ»æ»
æ©æ§ã«ã©ãžã«ã«ãé¢äžããŠããããšãå®èšŒã§ããããã®äºãããäºé
žåãã¿ã³ã»è¶
é³æ³¢ç
§å°æ³ã«ããã©ãžã«ã«ãçºçãããã®ã©ãžã«ã«ã现èæ»ãèªå°ããŠããããšã瀺åã§ãããç 究課é¡/é åçªå·:17016028, ç 究æé(幎床):2005åºå
žïŒãçµç¹èªèèœãæããäºé
žåãã¿ã³ã»ããç²åã®æ°èŠããæ²»çãžã®å¿çšãç 究ææå ±åæžã課é¡çªå·17016028ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-17016028/)ãå å·¥ããŠäœ
ç°å¢å€åã®å容ãšè³ã»å ç«ç³»å¿çã«ãããèŸè亀æç¥çµã®æ©èœçæ矩
é沢倧åŠå·¥åŠéšæ¬ç 究ç®çã¯,åçš®ã¹ãã¬ã¹ç¶æ
ã«ãã£ãŠã²ãèµ·ãããã,æåžžæ§ç¶æã®ããã®çäœé²åŸ¡ã®äžæ¢çµ±åŸ¡æ©æ§ãæããã«ããããšã«ãã.ãã®ãã,(1)ç¥çµæŽ»æ§ç©è³ªã®åæ
ãç¡éº»é
ç¡ææã§è§£æã§ããèŸèãã€ã¯ããã€ã¢ãªã·ã¹æ³ã確ç«ã,(2)ããã«ããç°å¢ã»æ
åã¹ãã¬ã¹ããã³ã¹ãã¬ã¹é¢é£ç©è³ªã«ããèŸè亀æç¥çµæŽ»åæå¶æ©æ§ãèŸèãã«ã¢ãã¬ããªã³(NA)ã®åæ
ã¬ãã«ã§è§£æãã.ææã¹ãã¬ã¹éå§åŸ,èŸèNAã¯æœæ20å以å
ã«,åºç€éé¢éã®çŽ8åã«ãŸã§å¢å€§ããã®åŸ20åéæç¶ãã.ããã,ãã®åŸææã¹ãã¬ã¹ã®æç¶ã«ãããããã,NAã®éé¢ãæžåŒ±ããŠããããããé å¿åå¿ã芳å¯ãããã,ææ解æŸåŸãæ°æéã«ããã£ãŠææå眮ã®çŽ2åãšææã«é«ãã£ã.ãã®ææã¹ãã¬ã¹ã«ããNAã®éé¢ã¯,ãããããèŸè亀æç¥çµãåé€ããããšã«ããèåã«æå¶ãããããšãã,èŸè亀æç¥çµããéé¢ãããNAãåæ ããŠãããšèãããã.ãŸãææã¹ãã¬ã¹ã«ããèŸèããã¥ã©ã«ãã©ãŒçŽ°èã®æŽ»æ§ãææã«æå¶ãããã,ãã®æå¶ãèŸè亀æç¥çµã®åé€ã«ããææã«æžåŒ±ããããšãå€æãã.äžæ¹,corticotropin-releasingfctor(CRF)ã®åŽè³å®€å
æäž(2ÎŒg)ã«ãã,èŸèNAæ¿åºŠã¯2å³°æ§ã«å¢å€§ã,ããããæäºåŸ20åããã³140åã§æé«å€(æäžåå€ã®300%)ã瀺ãã.ããã«,IL-1βã®è
¹è
å
æäžã«ãã£ãŠãèŸèNAã¯ææã«å¢å€§ã,æäºåŸ40åã§æé«å€(æäžåå€ã®200%)ãšãªã£ãåŸç·©ããã«å埩ããã,æäºåŸ80åã«ãããŠããã®å¢å ã¯ææã§ãã£ã.ãã®IL-1βã®è
¹è
å
æäžã«ããèŸèNAã®å¢å ã¯,CRFå容äœã®æ®æè¬ã§ããα-helical CRFãåŽè³å®€å
ã«åæäžããããšã«ããææã«æžåŒ±ãã.以äžã®çµæã¯,ãµã€ãã«ã€ã³ã«ããç°å¢ã¹ãã¬ã¹ã»è³-å
ç«ç³»æ©èœé£é¢ã瀺åãã.ç 究課é¡/é åçªå·:08670079, ç 究æé(幎床):1996åºå
žïŒç 究課é¡ãç°å¢å€åã®å容ãšè³ã»å
ç«ç³»å¿çã«ãããèŸè亀æç¥çµã®æ©èœçæ矩ã課é¡çªå·08670079ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒ ïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-08670079/ïŒãå å·¥ããŠäœ
æ©èœæ§ãã€ãªèåããç²åãšè¶ é³æ³¢ååŠãã«ãããªã³ã°ããæ°èŠããæ²»ç
é沢倧åŠç°æ¥æ¬æµ·åç°å¢ç 究ã»ã³ã¿ãŒæã
ã¯å
觊åª(äºé
žåãã¿ã³)ã«è¶
é³æ³¢ãç
§å°ãããšæ¥µããŠåŒ·ãé
žååãæããOHã©ãžã«ã«ãé«æ¿åºŠã§çæããçŸè±¡ãå ±åãã(äºé
žåãã¿ã³ã»è¶
é³æ³¢è§Šåªæ³)ããã®çŸè±¡ãæ°èŠããæ²»çã«å¿çšããããšãæ¬ç 究ã®ç®çã§ããããã®ããBåèçãŠã£ã«ã¹å€ç®ã¿ã³ãã¯è³ª(preS1/S2ã¿ã³ãã¯è³ª)ãåºå®åããäºé
žåãã¿ã³ã»ããç²åãçšããŠ,in vitroã§ã®å¹é€ãã现èãžã®å蟌ã¿ããã³in vivoã§ã®äºé
žåãã¿ã³ã»è¶
é³æ³¢è§Šåªæ³ã«ããæè
«çå¹æãæ€èšãããæpreS1æäœãçšããå
ç«æè²æ³ã«ãã£ãŠpreSl/S2åºå®åäºé
žåãã¿ã³ã®è现èèªèèœã調ã¹ããpreS1/S2åºå®åäºé
žåãã¿ã³ãæ·»å ããå Žå,ããèèããç±æ¥çŽ°èã§ããHepG2ã«ãããŠåŒ·ãèµ€è²èå
ã瀺ãããäžæ¹,ãã倧è
žããç±æ¥çŽ°èã§ããWiDrã§ã¯preS1/S2åºå®åäºé
žåãã¿ã³ãæ·»å ããŠãèµ€è²èå
ã¯ç€ºããªãã£ãã以äžã®çµæãã,preS1/S2ã¿ã³ãã¯è³ªã¯è现èã«ç¹ç°çãªé åãæããã¿ã³ãã¯è³ªã§ãã,ãã€preS1/S2åºå®åäºé
žåãã¿ã³ã¯è现èã«ç¹ç°çã«åã蟌ãŸããããšãå€æãããããèèããç±æ¥çŽ°èæ ªHepG2ã移æ€ããæ
ããããŠã¹ãçšããŠäºé
žåãã¿ã³ã»è¶
é³æ³¢è§Šåªæ³ã«ããæè
«çå¹æã«ã€ããŠæ€èšãããäºé
žåãã¿ã³ç²åæ·»å æäžããã³è¶
é³æ³¢ç
§å°ã®æç¡ã«é¢ãããæéçµéãšãšãã«è
«çã¯æé·ããçµæãšãªã,ä»åã®äºé
žåãã¿ã³æäžæ¡ä»¶ããã³è¶
é³æ³¢ç
§å°æ¡ä»¶ã§ã¯äºé
žåãã¿ã³ã»è¶
é³æ³¢è§Šåªæ³ã«ããæè
«çå¹æã¯ç¢ºèªã§ããªãã£ããä»åŸ,in vitroã®å®éšã«ãããŠã¯,现èæ»ã®ã¡ã«ããºã ããã詳现ã«è§£æããããš,in vivoã®å®éšã«ãããŠã¯,äºé
žåãã¿ã³ç²åã®æäžæ¡ä»¶ããã³è¶
é³æ³¢ç
§å°æ¡ä»¶ã®æŽãªãæ€èšãå¿
èŠã§ããããŸã,ä»åäœè£œããpreS1/S2åºå®åäºé
žåãã¿ã³ç²åã®è现èç¹ç°æ§ã確èªãããã,ç²åã®äœå
æåã«é¢ããŠã解æãè¡ãå¿
èŠããããç 究課é¡/é åçªå·:18015019, ç 究æé(幎床):2006 â 2007åºå
žïŒãæ©èœæ§ãã€ãªèåããç²åãšè¶
é³æ³¢ååŠãã«ãããªã³ã°ããæ°èŠããæ²»çãç 究ææå ±åæžã課é¡çªå·18015019ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-18015019/)ãå å·¥ããŠäœ
ã©ãžã«ã«çºçæ©èœãæãããã€ãªèåããç²åã«ããæ°èŠããæ²»çæ³ã®ç¢ºç«
é沢倧åŠèªç¶èšæž¬å¿çšç 究ã»ã³ã¿ãŒããããã¯äºé
žåãã¿ã³ã«è¶
é³æ³¢ãç
§å°ããããšã«ãã掻æ§é
žçŽ (ã©ãžã«ã«åå)ãçºçããçŸè±¡ãèŠåºããããã®çŸè±¡ãããæ²»çãžã®æ°ããªææ³ãšããŠå¿çšããããšãæ¬ç 究ã®ç®çã§ãããæ¬ç 究ã§ææ¡ããè¶
é³æ³¢ç
§å°æ³ã«ãŠã©ãžã«ã«ãçºçãããã°ãç®èçµç¹ãèåšã®è¡šé¢ã ãã§ãªãæ·±éšã®ããçµç¹ã«ãããŠãæ²»çãå¯èœãšãªããé䟵襲çã§æ ¹æ²»æ§ã®é«ãããæ²»çæ³ãéçºã§ãããããã§æ¬ç³è«ç 究ã§ã¯(1)äºé
žåãã¿ã³è¡šé¢ã«çäœèªèååãé
ååããè¡æµäžã移åã§ããããæ§é åã®æ€èš(2)åµè£œããäºé
žåãã¿ã³ãšè¶
é³æ³¢ç
§å°æ³ãæ
ããåç©ã«é©çšããããšã§ãã©ã®ãããªããæ²»çã®å¹æãåŸããããã®2ç¹ã«ã€ããŠæ€èšãè¡ã£ãã(1)é
ã«ãããŠã¯ãäžå¿ã«ç£æ§ç²åãæããæ©èœæ§äºé
žåãã¿ã³åŸ®ç²åã®æ§ç¯ã確èªã§ããæ§ç¯åŸ®ç²åã®å
觊åªæŽ»æ§ãã¡ãã¬ã³ãã«ãŒå解ã«ãŠè©äŸ¡ããçµæãå
觊åªæŽ»æ§ãæããããšã確èªã§ãããæŽã«ããã¿ã³ã»ããç²åå
å
ãªããœãŒã ãæ§ç¯ã§ãããã现èãšã®èåå®éšã«çšããããšãåºæ¥ãã¬ãã«ã§ããããšãæãããšãªã£ãã(2)é
ã§ã¯ãè
«ç现èã®çåçã¯è¶
é³æ³¢ç
§å°æéã«äŸåããŠæžå°ããäºãæãããšãªã£ããè¶
é³æ³¢ç
§å°ã®ã¿ã§ãè
«ç现èæ»æ»
ã®å¹æã¯ã¿ããããã®ã®ãäºé
žåãã¿ã³ãæ·»å ããããšã§ããå¹æçã«è
«ç现èãæ»æ»
ã§ããããšãæãããšãªã£ããç 究課é¡/é åçªå·:15025227, ç 究æé(幎床):2003åºå
žïŒãã©ãžã«ã«çºçæ©èœãæãããã€ãªèåããç²åã«ããæ°èŠããæ²»çæ³ã®ç¢ºç«ãç 究ææå ±åæžã課é¡çªå·15025227ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-15025227/)ãå å·¥ããŠäœ
æ©èœæ§çäœååãé åããå 觊åªããç²åã®åµè£œãšãã®å»çå¿çš
é沢倧åŠç°æ¥æ¬æµ·åç°å¢ç 究ã»ã³ã¿ãŒæã
ã¯å
觊åª(äºé
žåãã¿ã³)ã«è¶
é³æ³¢ãç
§å°ãããšæ¥µããŠé
žååã®åŒ·ãOHã©ãžã«ã«ãé«æ¿åºŠã«çæããçŸè±¡ãå ±åããããã®ãäºé
žåãã¿ã³ãè¶
é³æ³¢è§Šåªæ³ãã«ãŠã©ãžã«ã«ãçºçãããã°,ç®èçµç¹ãªã©ã®è¡šå±€éšäœã ãã§ãªãèåšæ·±éšã®è
«ççµç¹ã«ãããŠãæå¹ãªæ²»çãå¯èœãšãªã,é䟵襲çãªæ°èŠããæ²»çæ³ãéçºã§ããããã®é䟵襲çãã€èåšæ©èœæž©ååã®ãæ°èŠããæ²»çæ³ããéçºããããã®åºç€æè¡ãšããŠ,ãè
«ç现èãç¹ç°çã«èªèããæ©èœæ§å
觊åªããç²åããäœè£œããããšãæ¬ç 究ã®ç®çã§ãããäºé
žåãã¿ã³ã¯ãã®çé»ç¹ãäžæ§ä»è¿ã«ãã,è¡šé¢åŠçãè¡ããã«äœå
ã«æäžããå Žå,ããç²åã容æã«åéããå¯èœæ§ããããç¹ã«è¡äžæäžã§ã¯æ§ã
ãªã¿ã³ãã¯è³ªãšã®çžäºäœçšãªã©,äžç¢ºå®ãªèŠçŽ ãæ°å€ãååšããããã®ããæ¬ç 究ã§ã¯ç²åè¡šé¢ãããªã¢ã¯ãªã«é
žã§ä¿®é£Ÿã,éé»ççžäºäœçšã§ããç²åã氎溶液äžã§å®å®ã«åæ£ãããããããçšããŠäºé
žåãã¿ã³æ¿åºŠå€åã«ãããã现èèæå·å¹æãæ€èšãããè¶
é³æ³¢ãç
§å°ããªãå Žå,äºé
žåãã¿ã³æ·»å ã«ããä¹³é
žè±æ°ŽçŽ é
µçŽ 掻æ§ã®ããããªå¢å€§ãèªããããããããšæ¯èŒããŠ,äºé
žåãã¿ã·ãæ·»å åŸã«è¶
é³æ³¢ç
§å°ãè¡ããš,äºé
žåãã¿ã³æ¿åºŠã«æ¯äŸããŠçŽ°èããã®ä¹³é
žè±æ°ŽçŽ é
µçŽ æŒåºãææã«å¢å€§ããããã®çµæã¯,äºé
žåãã¿ã³ãè¶
é³æ³¢è§Šåªæ³ã«ãã现èèæå·ãäºé
žåãã¿ã³ããçæããOHã©ãžã«ã«ã«èµ·å ããå¯èœæ§ã瀺åãããããã«å¹é€æ¶²äžã«äºé
žåãã¿ã³ç²åãæ·»å åŸ,ç现èæ°ã®çµæå€åã«å¯Ÿããè¶
é³æ³¢ç
§å°ã®åœ±é¿ã調ã¹ããäºé
žåãã¿ã³ç²åæ·»å ã®ã¿ã§ã¯çŽ°èã¯æ£åžžã«å¢æ®ããã®ã«å¯Ÿã,äºé
žåãã¿ã³ç²åæ·»å åŸã«è¶
é³æ³¢ãç
§å°ãããšç现èæ°ãçŽ50%ã«ãŸã§æžå°ã,ãã®åŸã®å¢æ®ãå®å
šã«æå¶ãããããŸãããç²åè¡šé¢ã®ã«ã«ããã·ã«åºãçšããŠåçš®æäœãGFPãªã©ã®ã¿ã³ãã¯è³ªã®ä¿®é£Ÿãè¡ããããšã確èªã,ãã现èãèªèããäºé
žåãã¿ã³ããç²åäœè£œã®åºç€ã確ç«ã§ãããç 究課é¡/é åçªå·:18650143, ç 究æé(幎床):2006 â 2007åºå
žïŒãæ©èœæ§çäœååãé
åããå
觊åªããç²åã®åµè£œãšãã®å»çå¿çšãç 究ææå ±åæžã課é¡çªå·18650143ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-18650143/)ãå å·¥ããŠäœ
ãã€ãªã¢ãã£ããã£ãå©çšããå€æ©èœãã€ãªã»ã³ã·ã³ã°ã·ã¹ãã ã®éçº
1.埮å°éæãã€ãªã»ã³ãµã®éçº (1)é
žåé»æµå€ã®ã°ã«ã³ãŒã¹æ¿åºŠäŸåæ§ ã°ã«ã³ãŒã¹æ¿åºŠäŸåæ§ã調ã¹ãçµæãé
žåé»æµå€ã¯ã°ã«ã³ãŒã¹æ¿åºŠã«æ¯äŸããŠå¢å ãããæ€åºéçæ¿åºŠã¯0.01mMã§ããããŸã5mM以äžã§ã¯çŽç·æ§ãèªããããªããªã£ããé
µçŽ åºå®ååã®é»æ¥µãšæ¯èŒããŠé»æµå€ã®åçŸæ§ã¯åªããŠããã (2)溶åé
žçŽ äŸåæ§ãšé»åã¡ãã£ãšãŒã¿ã®å°å
¥ ã°ã«ã³ãŒã¹ãªãã·ããŒãŒã¯ãã®åå¿éçšã§é
žçŽ ãå¿
èŠãšããããããã£ãŠäœæº¶åé
žçŽ ã®ç¶æ
ã§ã¯ãã»ã³ãµã®æ床ãäœäžããå¯èœæ§ããããäºãçªçŽ ã¬ã¹ããããªã³ã°ããããšã§æº¶åé
žçŽ æ¿åºŠãäœäžãããå Žåãæ床ã®äœäžãšå¿çæéã«å¯Ÿããæå®æ°ã®å¢å ãèŠãããããã§ãã»ã³ãé»åã¡ãã£ãšãŒã¿ãšããŠçœéé»æ¥µãšã°ã«ã³ãŒã¹ãªãã·ããŒãŒã®éã«ä»åšãããããšã§ãäœæº¶åé
žçŽ é åã§ãã»ã³ãµã®æ床ãç¶æããããšãã§ããã (3)pHã®åœ±é¿ é
µçŽ ã«ã¯è³é©pHããããã»ã³ãµã®èå¥çŽ åãšããŠçšããå Žåã«ã¯pHã®åœ±é¿ã調ã¹ãå¿
èŠããããããã§ã°ã«ã³ãŒã¹ãªãã·ããŒãŒæº¶æ¶²ãpH=5.6ãè©Šæ溶液ã®ã°ã«ã³ãŒã¹æ¿åºŠã1.0mMã«èšå®ãã溶液äžã®ãªã³é
žç·©è¡æ¶²ã®pH5.6ã8.0ãŸã§å€åãããè©Šæ溶液äžã®pHã®åœ±é¿ã調ã¹ãããã®çµæãpH5.6ãã7.5ã®ç¯å²ã«ãããŠè©Šæ溶液äžã®pHã®åœ±é¿ãåããªãããšãæãããšãªã£ããããã¯ãé
µçŽ ãéæèã«ãã£ãŠå€æ¶²ã®pHå€åããä¿è·ãããŠãããããšèããããã 2.æ°Žæ¶æ¯ååãçšããå
ç«ã»ã³ãµã®éçº AT-cutã®æ°Žæ¶æ¿äžã«éãèžçããããšãŸå§é»å¹æãå©çšããè¶
埮å°é質é枬å®ã»ã³ãµãäœè£œããé»æ¥µè¡šé¢ã«ã€ã®æããIgGãåºå®åããIgGã®æž¬å®ã«ã€ããŠæ€èšãããæäœã¯éé»æ¥µè¡šé¢äžã«ãã©ãã³ãé»è§£éååŸããã©ãã³-ã°ã«ã¿ã«ã¢ã«ããããŒæäœã®ã¢ããåºéã«ã·ããå¡©ã圢æãããããšã«ããå®å®ã«åºå®åããããšãã§ããããã®ã»ã³ãµã®é»æ¥µè³ªéå€åãšåºæ¬æ¯åæ°ãšã®éã«ã¯æ¯äŸé¢ä¿ãæç«ãããã®æ床ã¯1ng/Hzã§ãã£ããåçš®æ¿åºŠã®ããIgG溶液ã«å¯Ÿããå
ç«ã»ã³ãµå¿çã®çµæçå€åã調ã¹ãçµæãIgGæäžã«ãã£ãŠæ¯åæ°ã極ããŠãã£ãããšããæéçµéã§å€åããIgG50ÎŒg/mlæäžã§ã¯çŽ20ååŸã«æ倧æ¯åæ°å€åã200Hzã«éãããThe purpose of this research project was to accomplish the biosensing system which can detect the endogenous chemical substances influencing neuronal activities in the brain. For this purpose, the characteristics of the following sensors were studied ; (1) enzyme microdialysis biosensor and (2) a quarts crystal microbalance biosensor for immunosorbent assay.1. Enzyme microdialysis biosensorThe concentric biosensor was consisted of glass body with a semi-permeable membrane at the tip, working electrode and an inlet and outlet capillary for the perfusion of enzyme solution. The working electrode and the inlet capillary were inserted into a semi-permeable hollow fiber (o.d.=220 ÎŒm). The advantage of the biosensor was that the micro-environment around the working electrode could be easily changed by perfusing the enzyme solution. Glucose oxidase was used in this study and steady state response of the sensor was proportional to the glucose concentration up to 5mM.The detection limit of the glucose concentration was 0.01 mM.The decrease in the sensitivity caused by the reduction of dissolved oxygen concentration was overcome by using ferrocene carboxyaldehyde as an electron mediator.2. Quarts crystal microbalance biosensorThe piezoelectric crystals were studied under various operational conditions and were also applied to the determination of human IgG concentration. AT-cut crystals, with a basic resonant frequency of 9 MHz, were modified by immobilizing goat anti-human IgG onto the surface of crystal electrode with tyramine and glutaraldehyde. The immobilization technique improved the long term stability of the biosensor, and the change in frequency caused by the adsorption of material onto the surface of electrode was confirmed to be 1 Hz/ng. The shift in frequency resulting from the reaction of human IgG and goat anti-human IgG correlated with a concentration range of 10ÎŒg/ml-50 ÎŒg/ml. The suitability of this technique for neurophysiological studies was confirmed for investigation of the chemical fluctuations in vivo.ç 究課é¡/é åçªå·:10557006, ç 究æé(幎床):1998â2000åºå
žïŒããã€ãªã¢ãã£ããã£ãå©çšããå€æ©èœãã€ãªã»ã³ã·ã³ã°ã·ã¹ãã ã®éçºãç 究ææå ±åæžã課é¡çªå·10557006(KAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒ)ãããæ¬æããŒã¿ã¯èè
çå ±åæžããäœ
ãã€ãªã¢ãã£ããã£ãå©çšããçç掻æ§ç©è³ªã®æ°èŠåŸ®éå®éæ³ã®ç¢ºç«
é沢倧åŠå·¥åŠéšçš®ã
ã®ååŠç©è³ªã枬å®å¯Ÿè±¡ãšãããã€ãªã»ã³ãµã®éçºã泚ç®ãããŠãããããããã®å€ãã¯é
žåé
µçŽ ã«ãã£ãŠçºçããéé
žåæ°ŽçŽ ã®é
žåé»æµå€ãé»æ°ååŠçã«æ€åºããæ¹åŒã§ããã枬å®ç©è³ªãéå®ãããç¥çµãããããªã©ã®æž¬å®ã«é©çšããäŸã¯ãªããæ¬ç 究ã¯æ°Žæ¶æ¯ååãé«æ床ãã€ã¯ããã©ã³ã¹ãšããŠå©çšããæåã»æäœåå¿ã«ãã£ãŠçããé»æ¥µè¡šé¢äžã§ã®ç¹ç°ç質éå€åãæ°Žæ¶æ¯ååã®åºæ¬åšæ³¢æ°å€åããæ±ãããšããæ°èŠã®çºæ³ã§ããããã®ããã(1)æ°Žæ¶æ¯ååãé«æ床ãã€ã¯ããã©ã³ã¹ãšããŠå©çšããããã®çè«è§£æãšç¹æ§è©äŸ¡åã³é«æ床åã(2)æäœãªã©ã®çäœç©è³ªãããã«å¹çããããŸã掻æ§ãç¶æããŠåºå®åãããã«ã€ããŠè¿œåãã以äžã®ææãåŸãã(1) AT-cutã®æ°Žæ¶çµæ¶æ¿äžã«éãèžçããããšãŸå§é»å¹æãå©çšããæ°Žæ¶æ¯ååã»ã³ãµãäœè£œããããã®æ°Žæ¶æ¯ååã®é»æ¥µã®è³ªéå€åãšåºæ¬æ¯åæ°ãšã®éã«ã¯æ¯äŸé¢ä¿ãæç«ããæ°Žæ¶æ¯ååã®ãã€ã¯ããã©ã³ã¹(埮é倩秀)ãšããŠããã°ã©ã ãªãŒããŒã§ã®åŸ®éæåã®æ€åºã»å®éãå¯èœã§ãã£ããæå®æ¿åºŠã®NaCl氎溶液ããµã³ãã«æ¶²ãšããŠé»æ¥µè¡šé¢ã«æ¢ç¥éã®èžçºæ®çç©ã圢æããããã®æ®çç©è³ªéãšåºæ¬æ¯åæ°ã®å€åéã調ã¹ãããã®çµæãé»æ¥µäžã®æ®çç©è³ªé(10ã100ng)ãšæ¯åæ°å€åãšã®éã«ææãªçŽç·é¢ä¿ãèªãããããã®åŸãã¯1.0Hz/ngã§ãã£ãã(2) ãã©ãã³ã®é»è§£éåã«ãããé»æ¥µè¡šé¢ã«ã¢ããåºãå°å
¥åŸãã°ã«ã¿ã«ã¢ã«ãããã®æ¶æ©åå¿ã«ããæäœã®ã¢ããåºãšã®éã«ã·ããå¡©åºã圢æãããããã«ããé»æ¥µè¡šé¢ã«æäœãå®å®ã«åºå®åã§ããã(3) æ°Žæ¶æ¯ååãã€ã¯ããã©ã³ã¹å
ç«ã»ã³ãµãçšããŠæå-æäœåå¿ã®æ€åºãå¯èœã§ãããæåæ¿åºŠãšå
ç«ã»ã³ãµã®å¿çã«ã¯ææãªçžé¢ãèªãããããç 究課é¡/é åçªå·:09877017, ç 究æé(幎床):1997 â 1998åºå
žïŒç 究課é¡ããã€ãªã¢ãã£ããã£ãå©çšããçç掻æ§ç©è³ªã®æ°èŠåŸ®éå®éæ³ã®ç¢ºç« ã課é¡çªå·09877017ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒ ïŒhttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-09877017/ïŒãå å·¥ããŠäœ
ç°å¢ã»æ åã¹ãã¬ã¹é¢é£ç©è³ªã®åæ ãšèŠåºäžéšçäœèŠåæ å ±åŠçæ©æ§ã®è§£æ
1.ææã¹ãã¬ã¹ã«ããæé£è¡åã®æå¶ (1)ææã¹ãã¬ã¹ã«ãã£ãŠæé£éã®ææãªäœäžãèµ·ãããããã¯ã»ãããã³å容äœæ®æè¬ã®methysergideããã³ã»ãããã³1Aã¬ã»ãã¿ãŒã®ç¹ç°çã¢ãŽãã¹ãã§ãã8OH-DPATã®åæäžã§ææã«æ®æãããã (2)æäžå®äœçšãæããdiazepam(DZP)ã®æäžã¯çæœæã§æé£è¡åãèªèµ·ããããããã¯DZPã®partial inverse agonistã§ãããäžå®æ¹èµ·äœçšãæããFG7142ã®æäžã§ææã«æ®æã§ããã 2.èŠåºäžéšã»ãããã³ããã³å
åŽåé åéãã«ã¢ãã¬ããªã³(NA)ã®åæ
(1)ææã¹ãã¬ã¹åŸèŠåºäžéšå€åŽéã§ã»ãããã³ã®éé¢ãææã«å¢å ããããã¯DZPãããã¯8OH-DPATã®åæäžã«ããå®å
šã«é»å®³ã§ãããå
åŽåé åéã§ã®NAã®éé¢ãææã¹ãã¬ã¹ã«ãã£ãŠææã«å¢å€§ããããããã¯benzodiazepineç³»ãCRFç³»ã«ãã£ãŠä¿®é£ŸãããŠããå¯èœæ§ãããã (2)ææã¹ãã¬ã¹ã«ããå
åŽåé åéã®NAéé¢ã¯CRFã®ç¹ç°çæ®æè¬ã§ããα-herical CRFã倧è³åŽè³å®€å
ãžåæäžãããšææã«æ®æã§ããããŸãCRFã®åŽè³å®€å
æäžã«ããçæœæã§å
åŽåé åéã®NAéé¢ãä¿é²ãããã 3.èŸè亀æç¥çµçµæ«ããã®NAéé¢ ææã¹ãã¬ã¹ã¯èŸè亀æç¥çµããã®NAéé¢ãææã«ä¿é²ããããšããã€ã¯ããã€ã¢ãªã·ã¹æ³ã§æããã«ãããããã¯èŸèãæ¯é
ãã亀æç¥çµã®åé€ã«ãã£ãŠææã«æãããããããã«ææã¹ãã¬ã¹ãè² è·ãããšãã«å
ç«åå¿(NK掻æ§)ãäœäžãããããé€ç¥çµã«ããææã«æ®æãããããšãªã©ãããèŸè亀æç¥çµçµæ«ããæŸåºããããã«ã¢ãã¬ããªã³ãNK掻æ§ãæå¶ãããšèãããããThis study was designed to study the dynamic changes in serotonin (5HT) and noradrenaline (NA) levels during the stressful stimuli, and have reached the following conclusions in rats. (1) Immobilization-stress caused anorexia in conjunction with an immediate increase in thehypothalamic 5HT release. Injection of 5HT receptor antagonist significantly reduced the immobilization-induced anorexia, suggesting that the hypothalamic serotonergic ystem is activated during stress and 5HT is an inhibitory transmitter in feeding behavior. (2) Immobilization elevated NA levels in the medial prefrontal cortex (PFC). Pre-injection of a benzodiazepine receptor agonist, diazepam, significantly attenuated the immobilization-induced NA release, while the injection of an anxiogenic compound, FG7142, facilitated it in non-stressed condition. Thus the stressfull stimuli activate the NA system in the medial PFC which may be modulated by an activation of the benzodiazepine receptors in the brain. (3) Immobilization-stress rapidly increased NA levels of spleen in conjunction with the suppression of natural killer (NK) cytotoxicity. Both theincreased levelsof NA ad he suppresion of NK cytotoxicity were significantly attenuated after surgical denervation of the splenic sympathetic nerve, indicating that immobilization-induced suppression of splenic N/K cytotoxicity was mediated predominantly through enhanced activity of the splenic sympathetic nerve..These results suggest that both 5HT and NA may act asneurotransmitters and/or neuromodlators which regulate biowarning processes in the living body.ç 究課é¡/é åçªå·:04670095, ç 究æé(幎床):1992â1993åºå
žïŒãç°å¢ã»æ
åã¹ãã¬ã¹é¢é£ç©è³ªã®åæ
ãšèŠåºäžéšçäœèŠåæ
å ±åŠçæ©æ§ã®è§£æãç 究ææå ±åæžã課é¡çªå·04670095(KAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒ)ãããæ¬æããŒã¿ã¯èè
çå ±åæžããäœ
- âŠ